BRIEF-AstraZeneca Says Ultomiris Recommended In EU For Children With Paroxysmal Nocturnal Haemoglobinuria

BRIEF-AstraZeneca Says Ultomiris Recommended In EU For Children With Paroxysmal Nocturnal Haemoglobinuria
Representative Image Image Credit: ANI
  • Country:
  • United States

AstraZeneca PLC: * ASTRAZENECA PLC - ULTOMIRIS RECOMMENDED IN EU FOR CHILDREN WITH PNH

* ASTRAZENECA - ULTOMIRIS RECOMMENDED FOR APPROVAL IN EU BY CHMP FOR CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA * ASTRAZENECA - ULTOMIRIS RECOMMENDED FOR APPROVAL IN EU BY CHMP FOR CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA Source text for Eikon: Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.